FDA Approved: BAVENCIO — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BAVENCIO (avelumab) submitted by EMD Serono, Inc. This entry serves as the official notice of the approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

SUPPL AP for BAVENCIO (AVELUMAB)